Profitmed

The main activity of ProfitMed CJSC is distribution pharmaceutical products, goods for beauty and health of leading domestic and foreign manufacturers. As of March 2019, ProfitMed includes subsidiaries in federal districts and representative offices in the regions.

History

2023

Introduction of observation procedure

In May 2023, the Moscow Arbitration Court introduced a monitoring procedure at Profitmed. The amount of claims against the distributor is almost billion rubles.

According to Vedomosti, Profitmed's problems began at the end of 2022, when the company's counterparties began to massively apply to the courts with a demand to repay debts. According to the SPARK-Interfax system, a total of 38 claims for 541 million rubles were filed against Profitmed in 2022. In 2023, the number of such applications increased by another 115. Among the largest plaintiffs is Aresbank, which belongs to the main owner of Pharmstandard, Viktor Kharitonin. The bank is seeking a refund of more than 570 million rubles.

The court introduced a monitoring procedure in the pharmaceutical distributor Profitmed

The publication could not find out why the pharmaceutical distributor abruptly stopped paying its counterparties. Experts interviewed by Vedomosti say that Profitmed is unlikely to be able to pay off creditors. According to the company's latest financial statements, over the past year, the size of its assets decreased by 30%, and revenue fell by 20%, said Alexey Sharov, managing partner of Averty group. Elena Gladysheva, managing partner of the RI Consulting law firm, also speaks about this. She draws attention to the fact that at the end of 2022, Profitmed recorded a net loss.

Among the founders of Profitmed by the beginning of 2023 were Dmitry and Olga Svirin, FC Profit Houzz (one of its founders is Viktor Kharitonin), Chairman of the Board of Directors of the pharmaceutical distributor Evgeny Strigas and others. By May 2023, the company's shareholders are hidden. The official website of Profitmed does not work, the company does not respond to media requests.^[1]

Polisan recovered 282 million rubles from Profitmed

The manufacturer of antiviral drugs Polisan collected 282.4 million rubles from the pharmaceutical distributor Profitmed. This became known on May 22, 2023.

The Polisan lawsuit, owned by Alexander Borisov and Alexei Kovalenko, was filed in February 2023. The reason for the dispute was the supply of medicines, the contract for which was concluded in 2015.

Polisan recovered 282 million rubles from the pharmaceutical distributor Profitmed

In the period from September to December 2022, Polisan shipped Profitmed products for 296.6 million rubles. In December of the same year, the defendant transferred a little more than 7 million rubles to the St. Petersburg company.

In addition, Profitmed returned the goods to Polisan for 30.7 million rubles. As well as the defendant, claims were made to the plaintiff for partial marriage of goods totaling 5.3 thousand rubles.

Profitmed did not respond to Polisan's claims, in which he demanded to pay for the goods in full, as well as a penalty for delay.

In May 2023, the Arbitration Court of St. Petersburg and the Leningrad Region recognized Polisan's claims as justified and recovered 258.9 million rubles of debt and 23.5 million rubles of penalties from Profitmed in its favor.

Judging by the data of the Kontur. Focus service, since the beginning of 2023, about a dozen companies have announced their intention to file bankruptcy lawsuits against Profitmed, including two banks - Sber and Zenit.

Bankruptcy proceedings have been initiated against Profitmed. In January 2023, the claim for bankruptcy of ZAO Profitmed was filed with the Moscow Arbitration Court by the St. Petersburg supplier of medical products Ecliff.

The Preobrazhensky District Court of Moscow in January 2023, at the suit of Sberbank, as an interim measure, arrested all the property of Profitmed and its co-founder Dmitry Svirin within the amount of debt to the bank, including medicines, Profitmed equipment and Svirin's real estate.^[2]

The arrest of all property at the suit of Sberbank

On March 29, 2023, it became known that the Preobrazhensky District Court of Moscow arrested all the property of the pharmaceutical distributor Profitmed and its co-founder Dmitry Svirin.

The decision was made at the suit of the Moscow Bank of Sberbank, filed in January 2023. The initiators of the proceedings asked to collect the debt on loans and foreclose on the pledged property. The defendants were Profitmed JSC, Profitmed St. Petersburg LLC and Dmitry Svirin.

Sberbank asked to collect debt on loans and foreclose on pledged property

The court granted the petition of Sberbank, arresting the medicines, forklift and equipment of Profitmeda, which is pledged by the bank. In addition, Svirin's property was arrested: two apartments in Moscow and the Moscow region, two parking spaces, land in the Ramensky district of the Moscow region with a total area of ​ ​ more than 10 thousand square meters and three houses. Svirin's shares in Verkhauz SPb LLC (manages a warehouse in St. Petersburg; entrepreneur owns 23%), Nashotel LLC (manages the hotel of the same name in St. Petersburg; Svirin has 22.37%), OOO Otelmanatsiya (23%), ZAO Verkhaus Nord (50%), JSC FC Profit House (share not indicated), ZAO Fin BEST (owns LLC Profitpab, managing the Stairs bar on Petrovka in Moscow).

Profitmed tried to appeal the court decision, but it was upheld. A bankruptcy procedure has already been initiated against the pharmaceutical distributor. As it turned out during the proceedings, part of the arrested amount is on the collateral account of Profitmeda in Aresbank - 563.3 million rubles. Aresbank demands through the court to release these funds and remove the arrest from part of the goods, which are also pledged. In addition, Profitmed owes 282.4 million rubles to the pharmaceutical company Polisan, which in February 2023 secured the arrest of these funds in the distributor's accounts.

1994: Education

ProfitMed CJSC was established in 1994 by ProfitHouse FC, whose shareholders at that time were Alexey and Olga Svirin and Viktor Kharitonin (the main owner of the largest drug manufacturer in Russia, Pharmstandard). Current information about beneficiaries has not been disclosed.^[3]

Notes